Skip to main content
Skip to content
Case File
efta-efta01521721DOJ Data Set 10Correspondence

EFTA Document EFTA01521721

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521721
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT. For the Period 7/1/13 to 7/31/13 Equity Summary Asset Categories Beginning Market Value Ending Market Value Change In Value Current Allocation Asset Categories US Large Cap Equki 45.37453 301 48401 256,109.48 6% US SmaNdld Cap Equity 4,500.00 3930.00 (570.00) 1% Non-US E4uMy 122.08 134.40 12.32 Preferred Stocks Preferred Stocks 447,872.00 444,970.00 (2,902.00) 9% Concentrated 8 Other Equity 216.608.50 216,549.50 (59.00) 4% Non-US Equity Total Value 5714.477.11 $967,067.91 $252,590.80 21% VS SmaWASO Cap Equity _L Market Value/Cost Current Period Value Market Value 967067.91 Tax Cost 944.36224 Unrealized Gain/Loss 22,705.67 Estimated Annual Income 50,706.16 Accrued Dividends 4,851.85 Yield 5.23% Equity Detail Concontratea & ntnav Equity Equity as a percentage of your portfolio - 21 % US Large Cap &Nay Price Quantity Value Adjusted Tax Cost Original Cost Unrealized Est. Annual Inc. Gain/Loss Accrued Div. Yield US Large Cap Equity APACHE CORP 037411-M5 APA 80.25 95.000 7,823.75 11,403.30 (3,779.55) 76.00 1.00% 19.00 JP Morgan Page 5 of 33 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049140 SDNY_GM_00318338 EFTA01521721

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.